NCT06458231

Brief Summary

  • Review key history and clinical examination findings of cases with CLABSI.
  • Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI.
  • Determine antibiotic biogram of each organism isolated
  • Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

June 25, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

3 months

First QC Date

June 9, 2024

Last Update Submit

June 9, 2024

Conditions

Keywords

CLABSI, Primary B.I., Secondary B.I.

Outcome Measures

Primary Outcomes (2)

  • • Microbiological diagnosis and Culture sensitivity tests

    • Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI.

    6 months

  • Determine antibiotic biogram of each organism isolated

    Determine antibiotic biogram of each organism isolated

    6 months

Secondary Outcomes (1)

  • •Determine the prevalence of occurrence of Primary or secondary Blood stream infection

    4 months

Study Arms (4)

No of Positive CLABSI

No of +ve CLABSI in different types of cases,

Device: Blood Catheters

Primary Blood stream infection

Participant with blood stream infection not related to other other infection in the body

Device: Blood Catheters

Secondary Blood stream infection

Blood stream infection occur as a complication to infection in other parts of the body

Device: Blood Catheters

Blood Prevalence of types microorg.

% and Prevalence of different microorg causing Blood stream infection

Interventions

Central line as a predisposing factor for Blood stream infection

No of Positive CLABSIPrimary Blood stream infectionSecondary Blood stream infection

Eligibility Criteria

Age1 Day+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Venous blood samples from cases with suspected sepsis, or bacteremia will be incubated with a medium which encourages promotes bacterial growth.

You may qualify if:

  • Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture.
  • Both sex, and all age-groups.

You may not qualify if:

  • Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours.
  • Samples proved contaminated by microbial flora will be rejected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Prof. Refat Sadeq

Port Said, 22223, Egypt

RECRUITING

Faculty of Medicine Portsaid Uni

Port Said, Egypt

RECRUITING

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2024

First Posted

June 13, 2024

Study Start

June 25, 2024

Primary Completion

September 30, 2024

Study Completion

May 31, 2025

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Publication in Medical journals

Shared Documents
CSR
Time Frame
after one year

Locations